Raymond James Financial’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.29M	Buy	74,466 +22,488	+43%	+$389K	﹤0.01%	3394
2025 Q1	$1.14M	Buy	51,978 +2,963	+6%	+$64.8K	﹤0.01%	3380
2024 Q4	$1.56M	Buy	+49,015	New	+$1.56M	﹤0.01%	3138